A Trial of Tolvaptan in Children and Adolescent Subjects With Euvolemic and Hypervolemic Hyponatremia
Clinical trial NCT02442674 · WITHDRAWN
Trial details
- NCT number
- NCT02442674
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-06-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.